<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04612218</url>
  </required_header>
  <id_info>
    <org_study_id>BIO-FAST</org_study_id>
    <nct_id>NCT04612218</nct_id>
  </id_info>
  <brief_title>Biomarkers for Initiating Onsite and Faster Ambulance Stroke Therapies</brief_title>
  <acronym>BIO-FAST</acronym>
  <official_title>Biomarkers for Initiating Onsite and Faster Ambulance Stroke Therapies (BIO-FAST)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Virgen Macarena</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospitales Universitarios Virgen del Rocío</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Alta Resolución Sierra Norte</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital San Juan de Dios Aljarafe</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario Reina Sofia de Cordoba</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitario Virgen Macarena</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stroke is the first cause of death among Spanish women and main cause of disability.&#xD;
      Reperfusion therapies of the occluded artery remain the only useful approach in acute&#xD;
      ischemic stroke. However, the efficacy of these strategies is highly time-dependent and due&#xD;
      to the need of neuroimaging (CT or MRI) to differentiate between ischemic and hemorrhagic&#xD;
      stroke, impossible to be performed at the pre-hospital level. The investigators aim to set-up&#xD;
      a point of-care (POC) device to validate a biomarker panel differentiating ischemic and&#xD;
      hemorrhagic stroke at the pre-hospital level using a blood sample and to validate a second&#xD;
      biomarker panel for the early identification of patients with large vessel occlusions (LVO),&#xD;
      which are candidates for mechanical thrombectomy. For that, the investigators will recruit a&#xD;
      300 patients' cohort with pre-hospital blood samples using available POCs for each of those&#xD;
      markers.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 8, 2019</start_date>
  <completion_date type="Actual">July 28, 2021</completion_date>
  <primary_completion_date type="Actual">July 28, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Stroke subtype diagnostic accuracy</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
    <description>Stroke subtype diagnostic (% ischemic versus % hemorrhagic and % stroke mimics) will be determined by clinical and neuroimaging criteria at hospital arrival and compared with diagnostic accuracy of a blood biomarkers based test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reperfusion rates</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Times to reperfusion</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
  </primary_outcome>
  <enrollment type="Actual">176</enrollment>
  <condition>Stroke</condition>
  <condition>Ischemic Stroke</condition>
  <condition>Hemorrhagic Stroke</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients older than 18 years old, in whom health care services activate a stroke code, and&#xD;
        the patient is transferred to the reference centre, within 6 hours from symptoms onset.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  I.1: Patients &gt; 18 years old.&#xD;
&#xD;
          -  I.2: Stroke code activated by the coordinator centre.&#xD;
&#xD;
          -  I.3: &lt; 6 hours from symptoms onset. In the case of stroke with uncertain chronology or&#xD;
             wake-up stroke, the initial time will be considered as the last moment the patient was&#xD;
             seen fine.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  E.1: Prehospital diagnosis different of stroke.&#xD;
&#xD;
          -  E.2: Impossibility of getting a prehospital blood sample.&#xD;
&#xD;
          -  E.3: Refusal to provide the informed consent by the patient/relative.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joan Montaner, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitario Virgen Macarena</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital de Alta Resolución Sierra Norte</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital San Juan de Dios Aljarafe</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 23, 2020</study_first_submitted>
  <study_first_submitted_qc>October 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2020</study_first_posted>
  <last_update_submitted>August 25, 2021</last_update_submitted>
  <last_update_submitted_qc>August 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Virgen Macarena</investigator_affiliation>
    <investigator_full_name>Joan Montaner Villalonga</investigator_full_name>
    <investigator_title>Head Department of Neurology</investigator_title>
  </responsible_party>
  <keyword>blood biomarkers</keyword>
  <keyword>stroke diagnosis</keyword>
  <keyword>stroke</keyword>
  <keyword>biomarkers</keyword>
  <keyword>reperfusion therapies</keyword>
  <keyword>acute stroke therapy</keyword>
  <keyword>prehospital stroke management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Hemorrhagic Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

